Case Reports
doi: 10.1017/s003329170001117x.
Caffeine abstention in the management of anxiety disorders
Affiliations
- PMID: 2727208
- DOI: 10.1017/s003329170001117x
Item in Clipboard
Case Reports
Caffeine abstention in the management of anxiety disorders
Psychol Med.
1989 Feb.
Abstract
Caffeine toxicity remains a rarely reported condition, which may mimic anxiety disorders. Anxiety disorder patients do not consume toxic amounts of caffeine. However, increased sensitivity to caffeine in these patients has been suggested as contributing to their symptoms. Six cases of anxiety disorder are presented who improved with only caffeine abstention, and remained well for at least a six-month follow-up period.
Similar articles
-
Behavioral and cerebrovascular effects of caffeine in patients with anxiety disorders.Acta Psychiatr Scand. 1990 Jul;82(1):17-22. doi: 10.1111/j.1600-0447.1990.tb01348.x. Acta Psychiatr Scand. 1990. PMID: 2399815
-
Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence.Arch Gen Psychiatry. 1984 Nov;41(11):1067-71. doi: 10.1001/archpsyc.1983.01790220057009. Arch Gen Psychiatry. 1984. PMID: 6497568
-
The anxiogenic effects of caffeine.Postgrad Med J. 1990;66 Suppl 2:S18-24. Postgrad Med J. 1990. PMID: 2392393
-
Increased anxiogenic effects of caffeine in panic disorders.Arch Gen Psychiatry. 1985 Mar;42(3):233-43. doi: 10.1001/archpsyc.1985.01790260027003. Arch Gen Psychiatry. 1985. PMID: 2983630 Review.
-
Caffeine challenge test and panic disorder: a systematic literature review.Expert Rev Neurother. 2011 Aug;11(8):1185-95. doi: 10.1586/ern.11.83. Expert Rev Neurother. 2011. PMID: 21797659 Review.
Cited by
-
Psychologists' sensitivity to medical factors examined during standard psychological evaluations: A preliminary description.J Clin Psychol Med Settings. 1995 Dec;2(4):373-86. doi: 10.1007/BF01991683. J Clin Psychol Med Settings. 1995. PMID: 24226416
-
ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex.Neuropsychopharmacology. 2012 Feb;37(3):759-69. doi: 10.1038/npp.2011.253. Epub 2011 Oct 19. Neuropsychopharmacology. 2012. PMID: 22012471 Free PMC article.
-
Modelling anxiety in humans for drug development.Curr Neuropharmacol. 2007 Mar;5(1):65-72. doi: 10.2174/157015907780077114. Curr Neuropharmacol. 2007. PMID: 18615150 Free PMC article.